AlphaFold predicted structure
DHRS3 · O75911

Mean pLDDT
94.2/ 100
Very high
302 residues
Confidence breakdown
- Very high(≥ 90)79%
- Confident(70–90)20%
- Low(50–70)0%
- Very low(< 50)0%
Open interactive 3D viewer
AlphaFold (Jumper et al., 2021) · CC BY 4.0
dehydrogenase/reductase 3
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalRare syndromic craniosynostosis or isolated multisuture synostosis
BIALLELIC, autosomal or pseudoautosomalglaucoma
open-angle glaucoma
inherited hemoglobinopathy
placenta praevia
major salivary gland cancer
craniosynostosis
placental abruption
gastric cancer
neoplasm
Noonan syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Short-chain dehydrogenase/reductase 3
Catalyzes the reduction of all-trans-retinal to all-trans-retinol in the presence of NADPH
DHRS3 · O75911

Mean pLDDT
94.2/ 100
Very high
302 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0